Medically reviewed by Larysa Grevtsova, MD
GLP-1: A Hormone Your Body Already Makes
If you’ve spent any time researching weight loss options in 2026, you’ve almost certainly run into the term “GLP-1.” It’s become shorthand for an entire category of medications that has reshaped how doctors approach obesity treatment. But what actually is GLP-1, and why has it generated so much attention? This guide breaks down the science in plain language, so you can understand exactly what you’d be putting in your body before you commit to any program.
GLP-1 stands for glucagon-like peptide-1. It isn’t a synthetic invention — it’s a hormone your intestines naturally produce every time you eat, particularly after meals containing fat and carbohydrates. In a healthy digestive process, GLP-1 acts as a messenger between your gut and your brain, signaling that food has arrived and helping coordinate several downstream effects: insulin release, digestion speed, and appetite regulation.
The problem is that naturally occurring GLP-1 breaks down within minutes of being released. It simply doesn’t stick around long enough to have a lasting therapeutic effect. This is where GLP-1 receptor agonist medications come in: they are engineered to mimic the hormone’s action while resisting rapid breakdown, allowing them to remain active in the body for days rather than minutes.
How GLP-1 Medications Work in the Body
GLP-1 receptor agonists act on multiple systems simultaneously, which is part of why they’re so effective compared to older weight loss drugs that typically targeted just one mechanism.
1. They slow gastric emptying. Food stays in your stomach longer, which extends the feeling of fullness after a meal and reduces the urge to snack between meals.
2. They act on appetite centers in the brain. GLP-1 receptors exist in the hypothalamus, the part of the brain that regulates hunger and satiety. By activating these receptors, the medication reduces overall food intake and cravings, particularly for high-fat and high-sugar foods.
3. They improve insulin sensitivity. GLP-1 stimulates insulin release from the pancreas specifically when blood sugar is elevated, and it suppresses glucagon, a hormone that raises blood sugar. This is why the medication class was originally developed for type 2 diabetes before its weight loss effects were studied separately.
Together, these mechanisms create a sustained calorie deficit that doesn’t rely purely on willpower — a major shift from traditional diet approaches that ask patients to fight their own hunger signals for months or years.
The Main GLP-1 Medications Used for Weight Loss
Several brand-name and compounded medications fall under the GLP-1 umbrella. The two most clinically established active ingredients are:
- Semaglutide — the active ingredient in Ozempic (approved for diabetes) and Wegovy (approved specifically for chronic weight management). It’s a once-weekly injection.
- Tirzepatide — the active ingredient in Mounjaro (diabetes) and Zepbound (weight management). Tirzepatide is technically a dual agonist, acting on both GLP-1 and a second hormone receptor called GIP, which some research suggests may produce greater average weight loss than semaglutide alone.
Telehealth weight loss providers typically prescribe either brand-name versions of these medications or compounded formulations of the same active ingredients, depending on insurance coverage, availability, and cost considerations. We cover the differences between compounded and brand-name GLP-1 medications, and how insurance coverage works in 2026, in separate guides linked below.
Who Are GLP-1 Medications For?
These medications are generally prescribed for adults with:
- A body mass index (BMI) of 30 or higher (classified as obesity), or
- A BMI of 27 or higher accompanied by a weight-related health condition such as type 2 diabetes, high blood pressure, or sleep apnea
A licensed medical provider — whether in person or through telehealth — needs to review your health history before prescribing, since GLP-1 medications aren’t appropriate for everyone. People with certain personal or family histories of thyroid cancer, pancreatitis, or specific gastrointestinal conditions are typically screened out during the consultation process.
What Results Look Like
Clinical trials for semaglutide and tirzepatide have generally shown average weight loss in the range of 15–21% of starting body weight over roughly a year of consistent use, combined with lifestyle changes. Individual results vary considerably based on dosage, adherence, diet, and metabolic factors, and weight regain is common if the medication is discontinued without a maintenance plan — a topic we explore in detail in our guide on what happens after stopping GLP-1 treatment.
Common Side Effects
The most frequently reported side effects are gastrointestinal: nausea, constipation, diarrhea, and occasional vomiting, especially during dose increases. These effects are usually most noticeable in the first several weeks as the body adjusts and tend to diminish over time. A more complete breakdown of side effects and how providers help patients manage them is covered in our dedicated side-effects guide.
The Bottom Line
GLP-1 medications work by amplifying and extending a natural hormonal process your body already uses to manage appetite and blood sugar. That mechanism-based approach is why they’ve outperformed most previous generations of weight loss drugs in clinical settings. That said, they’re prescription medications with real physiological effects and require proper medical supervision — not a one-size-fits-all quick fix.
If you’re evaluating telehealth providers that prescribe GLP-1 medications, our comparison table and buyer’s checklist can help you understand what to look for before you choose a program.